Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q® available through Walgreens locations nationwide. The Asthma and Allergy Foundation of America (AAFA) applauds this effort to help thousands of Americans with their epinephrine needs during the back to school season, as supply issues have been reported to the U.S. Food and Drug Administration (FDA) by other manufacturers.
Manufacturing and insurance issues have made it hard for many members of our community to fill their prescriptions for epinephrine auto-injectors in recent months. But the drug epinephrine itself is not in short supply. This has become a serious concern for families of children with life-threatening food allergies. When families who manage food allergies are in fear for their children's lives because they can't get the medicine they need, our system is broken.
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.
Welcome to our first monthly advocacy update. My name is Jenna Riemenschneider, Director of Advocacy at the Asthma and Allergy Foundation of America (AAFA). I'm pictured above with Mark Vieth, Senior Vice President at Cavarocchi Ruscio Dennis Associates, at a meeting with Airlines for America.
Through this monthly blog series, I will update you on our advocacy efforts. We have already had a busy fall. This first post will include our September and October activity.
Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q® 0.15 mg and 0.3 mg available through Walgreens locations nationwide. This comes in an effort to help thousands of Americans with their epinephrine needs during the back to school season, as supply issues have been reported to the U.S. Food and Drug Administration (FDA) by other manufacturers.
FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product.
We have heard from members in our community that many are having trouble filling prescriptions for three of the four types of epinephrine auto-injectors: EpiPen® and EpiPen Jr® (distributed by Mylan) The authorized generic of EpiPen® and EpiPen Jr® (distributed by Mylan) Epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick® (distributed by Impax) This is due to possible shortages at pharmacies. Kids With Food Allergies has confirmed there is no shortage of the drug...
School is a common place for children to experience anaphylaxis – a serious allergic reaction. But the Weatherford Independent School District in Texas recently took a step backward. They created a policy that guides staff to give Benadryl® for severe allergic reactions, instead of unassigned stock epinephrine. But this goes against medical evidence.
[Press Release] Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic Authorized Generic Offered at More Than 50% Below Wholesale Acquisition Cost of EpiPen Auto-Injector HERTFORDSHIRE, England and PITTSBURGH, Dec. 16, 2016 / PRNewswire / -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the launch of the authorized generic for EpiPen ® (epinephrine injection, USP) Auto-Injector at a wholesale acquisition cost (WAC) of $300 per...
Good news, New Jersey! Governor Christie has signed a bill into law expanding access to epinephrine auto-injectors in public places. What does this mean for you? Under the law, a person who has completed a training program will be allowed to give epinephrine to anyone experiencing a severe allergic reaction, or anaphylaxis . Certain public places and businesses (such as restaurants, amusement parks, theaters, camps, etc.) will be allowed to have auto-injectors available for allergy...
The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your asthma and allergies prevent life-threatening emergencies. Make a pact to “ACT” to manage your asthma and allergies: “A” means have an action plan for asthma or anaphylaxis. “C” reminds you to carry emergency medicines and wear a medical ID to alert others of your condition. “T” calls for having a treatment plan that includes when to take your medicines and what to do in an emergency.
When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default. Finally, you'll never receive email notifications about content they create or likes they designate for your content.
Note: if you proceed, you will no longer be following .